Chronic recurrent warfarin-induced skin necrosis in a patient with a mechanical mitral valve: a diagnostic mimic of pyoderma gangrenosum

Authors

  • Shikha Magar Department of Medicine, Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India
  • Bharath Narayan Department of Medicine, Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India
  • N. Praveenkumar Department of Medicine, Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India
  • Akshay Rahul Nandi Department of Medicine, Dr. B. R. Ambedkar Medical College, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2349-2902.isj20251461

Keywords:

Warfarin-induced skin necrosis, Anticoagulation, Chronic skin ulcer, Wound management, Mechanical heart valve, Cutaneous adverse drug reaction

Abstract

Warfarin-induced skin necrosis (WISN) is a rare but potentially life-threatening complication of warfarin therapy, often presenting within the first few days of initiation. It is more commonly seen in patients with underlying protein C or S deficiencies. We report the case of a 60-year-old female with a history of rheumatic heart disease who underwent mitral valve replacement (MVR) and was on Acitrom (acenocoumarol) as long-term anticoagulation prophylaxis. She presented with chronic, recurrent painful skin lesions involving the right lower limb, buttocks, and bilateral axillae. These lesions evolved from hyperpigmentation to ulcerative necrosis over a span of two years. Laboratory investigations revealed deranged coagulation parameters, and histopathological examination confirmed the diagnosis of WISN. Upon clinical suspicion, Acitrom was promptly discontinued, and the patient was switched to low molecular weight heparin. Aggressive wound care, including daily dressings and debridement, was initiated. The patient’s condition gradually improved, and the necrotic lesions began to heal. This case highlights the importance of early recognition and prompt intervention in managing WISN. Timely discontinuation of warfarin and initiation of heparin therapy, along with supportive wound care, are crucial for favourable outcomes. This condition underscores the need for close monitoring of anticoagulation therapy and early diagnosis to prevent irreversible damage.

Metrics

Metrics Loading ...

References

Nsaful J, Ofori Adjei Y, Dedey F, Agboadoh N, Anyigba E, Pieterson W. Warfarin-induced skin necrosis: A rare condition. Ghana Medical J. 2020;54(4):269-73. DOI: https://doi.org/10.4314/gmj.v54i4.10

Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Academy Dermatol. 2009;61(2):325-32. DOI: https://doi.org/10.1016/j.jaad.2008.12.039

Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis. J Brit Surg. 2000;87(3):266-72. DOI: https://doi.org/10.1046/j.1365-2168.2000.01352.x

Rathore SS, Agarwal SK, Pande S, Singh SK, Mittal T, Mittal B. Pharmacogenetic aspects of coumarinic oral anticoagulant therapies. Indian J Clin Biochem. 2011;26(3):222-9. DOI: https://doi.org/10.1007/s12291-011-0133-3

Kakagia DD, Papanas N, Karadimas E, Polychronidis A. Warfarin-induced skin necrosis. Ann Dermatol. 2014;26(1):96. DOI: https://doi.org/10.5021/ad.2014.26.1.96

Abdul-Jabar HB, Geroulakos G, Philpott N, Fareed J. Warfarin-induced skin necrosis: A case report. Clin Applied Thrombosis/Hemostasis. 2006;12(1):101-4. DOI: https://doi.org/10.1177/107602960601200117

Zahra T, Jamil S, Ferman H, et al. Warfarin-induced skin necrosis in a 14-year-old female: A case report. Cureus. 2022;14(10):e30354. DOI: https://doi.org/10.7759/cureus.30354

Becker CG. Oral anticoagulant therapy and skin necrosis: Speculations on pathogenesis. The New Dimensions of Warfarin Prophylaxis. 1987;217-22. DOI: https://doi.org/10.1007/978-1-4757-5985-3_20

Fred HL. Skin necrosis induced by coumarin congeners. Texas Heart Institute J. 2017;44(4):233-36. DOI: https://doi.org/10.14503/THIJ-17-6430

Holbrook A, Schulman S, Witt DM, Per OV, Jason F, Michael JK, et al. Evidence-based management of anticoagulant therapy. Chest. 2012;141(2):e152S-84S. DOI: https://doi.org/10.1378/chest.11-2295

Kamada M, Kenzaka T. Successful treatment of warfarin-induced skin necrosis using oral rivaroxaban: A case report. World J Clin Cases. 2019;7(24):4285-91. DOI: https://doi.org/10.12998/wjcc.v7.i24.4285

Vahanian A, Beyersdorf F, Praz F, Milan M, Stephan B, Johann B, et al. 2021 ESC/EACTS Guidelines for the management of Valvular Heart Disease. Eur Heart J. 2021;43(7):561-632. DOI: https://doi.org/10.1093/eurheartj/ehab395

Murad A, Daly T, Mulligan N, Lenane P. Extensive warfarin-induced skin necrosis successfully treated with negative pressure wound therapy. BMJ Case Rep. 2014;2014:bcr2013203510. DOI: https://doi.org/10.1136/bcr-2013-203510

Biscoe AL, Bedlow A. Warfarin-induced skin necrosis diagnosed on clinical grounds and treated with Maggot debridement therapy. BMJ Case Rep. 2013;2013:bcr2012007455. DOI: https://doi.org/10.1136/bcr-2012-007455

Downloads

Published

2025-05-23

How to Cite

Magar, S., Narayan, B., Praveenkumar, N., & Nandi, A. R. (2025). Chronic recurrent warfarin-induced skin necrosis in a patient with a mechanical mitral valve: a diagnostic mimic of pyoderma gangrenosum. International Surgery Journal, 12(6), 1016–1022. https://doi.org/10.18203/2349-2902.isj20251461

Issue

Section

Case Reports